LifeStance Health Group Inc LFST

NAS: LFST | ISIN: US53228F1012   2/06/2025
5,880 USD (-1,01%)
(-1,01%)   2/06/2025

14 mei 2025 · LifeStance Names Vaughn Paunovich as Chief Technology Officer · Persbericht

15 april 2025 · LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions · Persbericht

1 augustus 2024 · LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations · Persbericht

1 mei 2024 · LifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica Ambassadors · Persbericht

12 maart 2024 · LifeStance Appoints Dr. Teresa DeLuca to Board of Directors · Persbericht

19 januari 2024 · LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer · Persbericht

3 november 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST · Persbericht

31 oktober 2023 · LFST INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages LifeStance Health Group, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - LFST · Persbericht

26 oktober 2023 · Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of LifeStance Health Group, Inc. (LFST) Investigation · Persbericht

11 mei 2023 · Gennev and LifeStance Health Partner to Provide Integrated Care for Women in Menopause · Persbericht

22 december 2022 · LifeStance Health Earns 2022 Great Place to Work Certification™ · Persbericht

3 november 2022 · LifeStance Health Appoints J. Michael Bruff as New Business Transformation Officer; David Bourdon as Chief Financial Officer · Persbericht

1 oktober 2022 · LIFESTANCE HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LifeStance Health Group, Inc. - LFST · Persbericht

17 september 2022 · LIFESTANCE HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LifeStance Health Group, Inc. - LFST · Persbericht

8 september 2022 · LifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires · Persbericht

3 september 2022 · LIFESTANCE HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LifeStance Health Group, Inc. - LFST · Persbericht

25 augustus 2022 · LFST Investors Have Opportunity to Lead LifeStance Health Group, Inc. Securities Fraud Lawsuit · Persbericht

20 augustus 2022 · LIFESTANCE HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LifeStance Health Group, Inc. - LFST · Persbericht

15 augustus 2022 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages LifeStance Health Group (LFST) Investors to Contact Firm's Attorneys, IPO-Related Securities Class Action Filed · Persbericht

13 augustus 2022 · LFST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against LifeStance Health Group, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case · Persbericht

Mijn selecties